Multiple signal pathways in obesity-associated cancer

被引:126
作者
Chen, J. [1 ]
机构
[1] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia
关键词
MAPK; obesity-associated cancer; PI3K; Akt; mTOR; STAT3; GROWTH-FACTOR-I; DIET-INDUCED OBESITY; BODY-MASS INDEX; MAMMALIAN TARGET; BREAST-CANCER; PHOSPHOINOSITIDE; 3-KINASE; COLORECTAL CARCINOGENESIS; CELL-PROLIFERATION; INSULIN; ACTIVATION;
D O I
10.1111/j.1467-789X.2011.00917.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is increasing worldwide and reaches to a large proportion of the population in developed countries. Thus, obesity-associated cancer has become a major health problem. Multiple cancer risk factors in obesity have been identified including insulin/insulin-like growth factor axis, adipokines and cytokines; and multiple intracellular signal pathways have been studied. However, the role of each signal pathway in obesity-associated cancer is controversial. In this review, the recent studies on signal pathways in obesity-associated cancer are summarized and a unified explanation is provided. Multiple risk factors could initially activate phosphoinositide 3-kinase (PI3K/Akt), mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3) pathways. With increased severity of obesity, mammalian target of rapamycin (mTOR), which is down-stream of both PI3K/Akt and MAPK, is highly activated. Activated mTOR in turn inhibits the PI3K/Akt pathway and further activates the STAT3 pathway. This may explain the activation of the PI3K/Akt pathway at the early stage of obesity and its inhibition at the later stage. mTOR inhibition may be used for cancer therapy, but it may be necessary to be combined with the PI3K/Akt inhibitor as decreased mTOR activity will release its feedback inhibition on the PI3K/Akt pathway, which is under the influence of multiple cancer risk factors in obesity. Thus, dual inhibitors of PI3K and mTOR may provide a novel approach.
引用
收藏
页码:1063 / 1070
页数:8
相关论文
共 86 条
[1]   Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship? [J].
Aggarwal, Bharat B. ;
Kunnumakkara, Ajaikurnar B. ;
Harikumar, Kuzhuvelil B. ;
Gupta, Shan R. ;
Tharakan, Sheeja T. ;
Koca, Cemile ;
Dey, Sanjit ;
Sung, Bokyung .
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS, 2009, 1171 :59-76
[2]   Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase [J].
Algire, Carolyn ;
Amrein, Lilian ;
Zakikhani, Mahvash ;
Panasci, Lawrence ;
Pollak, Michael .
ENDOCRINE-RELATED CANCER, 2010, 17 (02) :351-360
[3]   Interleukin-6 in bone metastasis and cancer progression [J].
Ara, Tasnim ;
DeClerck, Yves A. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (07) :1223-1231
[4]   Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma [J].
Aziz, Saadia A. ;
Jilaveanu, Lucia B. ;
Zito, Christopher ;
Camp, Robert L. ;
Rimm, David L. ;
Conrad, Patricia ;
Kluger, Harriet M. .
CLINICAL CANCER RESEARCH, 2010, 16 (24) :6029-6039
[5]   The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma [J].
Bhende, P. M. ;
Park, S. I. ;
Lim, M. S. ;
Dittmer, D. P. ;
Damania, B. .
LEUKEMIA, 2010, 24 (10) :1781-1784
[6]   Subcellular Localization of Cyclic AMP-Responsive Element Binding Protein-Regulated Transcription Coactivator 2 Provides a Link between Obesity and Breast Cancer in Postmenopausal Women [J].
Brown, Kristy A. ;
McInnes, Kerry J. ;
Hunger, Nicole I. ;
Oakhiil, Jonathan S. ;
Steinberg, Gregory R. ;
Simpson, Evan R. .
CANCER RESEARCH, 2009, 69 (13) :5392-5399
[7]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[8]   Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[9]   Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia [J].
Chapuis, Nicolas ;
Tamburini, Jerome ;
Green, Alexa S. ;
Vignon, Christine ;
Bardet, Valerie ;
Neyret, Aymeric ;
Pannetier, Melanie ;
Willems, Lise ;
Park, Sophie ;
Macone, Alexandre ;
Maira, Sauveur-Michel ;
Ifrah, Norbert ;
Dreyfus, Francois ;
Herault, Olivier ;
Lacombe, Catherine ;
Mayeux, Patrick ;
Bouscary, Didier .
CLINICAL CANCER RESEARCH, 2010, 16 (22) :5424-5435
[10]   The IL-23/IL-17 axis may be important in obesity-associated cancer by way of the activation of multiple signal pathways [J].
Chen, J. .
INTERNATIONAL JOURNAL OF OBESITY, 2010, 34 (07) :1227-1228